Interestingly, although not statistically significant, administration of two vector doses showed a trend toward achieving more therapeutic efficacy than a single dose.
← all excerpts
Mucosal gene therapy using a pseudotyped lentivirus vector encoding murine interleukin-10 (mIL-10) suppresses the development and relapse of experimental murine colitis.
1
—
—